Announcement

Jeifer Biotech is excited to announce the launch of the ultra-pure spironolactone API, an advanced substance for precise endocrine and cardiovascular treatments.

This new type of product has a purity of 99.95%, ultra-low contaminants, enhanced stability, and meets the strict requirements of modern precision medicine and clinical applications in children and adults.  Our GMP-certified facilities are currently in full operation, providing services to international pharmaceutical companies, contract development companies and healthcare distributors.

The high-end upgrade in the field of steroid APIs is accelerating. The large-scale mass production of ultra-high-purity spironolactone API has been achieved. With the product features of high purity and high stability, it can meet the precise clinical medication needs of multiple populations. It offers a wonderful new choice of high-quality raw materials for the global endocrine and cardiovascular pharmaceutical fields.